The polymorphic genotypes of IL-18 promoter -607 and -137 were previously found to be associated with the risk of esophageal squamous cell carcinoma [20] and prostate cancer [21] in China, colorectal cancer in Greece [22], ovarian cancer in the USA (Hawaii) [23], and breast cancer in Iran [24]. This evidence concerns the gene IL18 and breast carcinoma.